UK markets close in 7 hours 51 minutes

Akebia Therapeutics, Inc. (AKBA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.6700-0.1200 (-4.30%)
At close: 1:00PM EST
2.7200 +0.05 (+1.87%)
After hours: 04:17PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts6356
Avg. Estimate-0.31-0.28-1.68-0.69
Low estimate-0.34-0.32-1.93-0.94
High estimate-0.25-0.23-1.59-0.4
Year ago EPS-0.6-0.45-2.77-1.68
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts5266
Avg. Estimate51.38M40.91M206.05M252.17M
Low estimate46.5M36.82M200.47M215.14M
High estimate62M45M216M311.5M
Year ago sales56.7M55.72M295.31M206.05M
Sales growth (year/est)-9.40%-26.60%-30.20%22.40%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.4-0.29-0.32-0.32
Actual EPS-0.6-0.45-0.51-0.34
Difference-0.2-0.16-0.19-0.02
Surprise %-50.00%-55.20%-59.40%-6.30%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.31-0.28-1.68-0.69
7 days ago-0.29-0.28-1.57-0.72
30 days ago-0.29-0.31-1.58-0.78
60 days ago-0.29-0.31-1.59-0.78
90 days ago-0.29-0.31-1.59-0.78
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/A1
Up last 30 days1N/AN/A4
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2N/A21
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.48.30%N/AN/AN/A
Next qtr.37.80%N/AN/AN/A
Current year39.40%N/AN/AN/A
Next year58.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A